Other Solid Tumors
📧 Sign up to get email alerts when something new happens for Other Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-12Clinical Trial Update: TQB2928 Injection Combined Anlotinib Hydrochloride Capsule in Recurrent/Metastatic Osteosarcoma and Other Solid Tumors [Phase 1]
Phase 1 trial of TQB2928 injection combined with Anlotinib hydrochloride capsule for recurrent/metastatic osteosarcoma and other solid tumor…
-
CLINICAL_TRIALS trial_result · 2025-08-03Clinical Trial Update: Trial of TRX518 (Anti-GITR mAb) in Stage III or IV Malignant Melanoma or Other Solid Tumors [Phase 1]
A Phase 1 trial of TRX518, an anti-GITR monoclonal antibody, in unresectable stage III/IV malignant melanoma or other solid tumors has compl…
-
CLINICAL_TRIALS research · 2025-05-21Clinical Trial Update: Study of KRAS Neoantigen mRNA Vaccine (ABO2102) in Patients With KRAS -Mutated Solid Tumors [EARLY_Phase 1]
Early-phase study evaluating ABO2102, a KRAS neoantigen mRNA vaccine, in KRAS-mutated solid tumors including pancreatic cancer; recruitment …
-
CLINICAL_TRIALS trial_result · 2025-05-20Clinical Trial Update: A Study of JAB-3312 in Adult Patients With Advanced Solid Tumors in China [Phase 1]
The Phase 1 study of JAB-3312 in adults with advanced solid tumors in China has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-19Clinical Trial Update: Relative Bioavailability/Bioequivalence of Different Formulations of Selinexor, the Impact of Hepatic Impairment on Selinexor Pharmacokinetics, Tolerability and Antitumor Activity of Selinexor Combination Treatment [Phase 1, Phase 2]
The update reports on the relative bioavailability/bioequivalence of different selinexor formulations, the impact of hepatic impairment on s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-01-10Clinical Trial Update: KD6001 in Combination With Anti-PD-1 Antibody±Bevacizumab in Patients With Advanced HCC and Other Solid Tumors [Phase 1, Phase 2]
Clinical trial update for KD6001 in combination with anti-PD-1 antibody with or without bevacizumab in advanced hepatocellular carcinoma and…
-
CLINICAL_TRIALS trial_result · 2021-09-29Clinical Trial Update: Phase I/II Study of PDR001 in Patients With Advanced Malignancies [Phase 1, Phase 2]
Phase I/II trial update for PDR001 in advanced malignancies completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial update for rovalpituzumab tesirine in DL3-expressing advanced solid tumors shows termination with results posted.
-
CLINICAL_TRIALS trial_result · 2019-09-19Clinical Trial Update: A Phase I Clinical Study With Investigational Compound LTT462 in Adult Patients With Specific Advanced Cancers. [Phase 1]
Phase I trial update for investigational compound LTT462 in adults with advanced cancers; trial terminated with results posted.